Studies have shown that patients of breast cancer have lower absolute numbers of peripheral blood lymphocytes but increased numbers of functionally suppressive CD4+CD25+ regulatory T cells (Tregs) in the peripheral blood and tumor microenvironment [2, 3]. This evidence concerns the gene CD4 and neoplasm.